semaglutide in kidney disease Long-term outcomes of obesity and cardiovascular in the SELECT trial Semaglutide Impact on Diabetes and

The need for effective weight management solutions is evident, and Semaglutide offers a promising option

In recent years, a number of drugs have emerged that have significant cardio-renal protective effects in patients with diabetes, and a typical example is sodium-glucose cotransporter 2 inhibitor (SGLT2i), glucagon-like peptide-1 receptor agonist (GLP-1RA), and nonsteroidal mineralocorticoid receptor antagonist, finerenone

By slowing gastric motility, they help patients feel full sooner, reducing calorie intake and leading to substantial weight loss

Bad Breath (Halitosis): Saliva is a natural mouthwash

However, studies have shown that it may be associated with weight loss in individuals with type 2 diabetes